MedPath

A pilot randomized, controlled, clinical study assessing the non-inferiority of calcium channel blockade over alpha blockade on hemodynamic stability in the management of Pheochromocytoma/Paraganglioma (PPGL)

Phase 3
Completed
Conditions
Health Condition 1: null- Pheochromocytoma and Paragangliom
Registration Number
CTRI/2018/06/014604
Lead Sponsor
Diamond Jubilee Society Trust Seth GSMC and KEM Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
23
Inclusion Criteria

Patient with Pheochromocytomas/ paraganglioma (PPGL)

Exclusion Criteria

ï?? Pregnant patient

ï?? Ongoing immunosuppressive treatment

ï?? Psychiatric or other serious diseases

ï?? Patients unwillingness to participate in the study

ï?? Patient age < 18 yrs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Calcium channel blockade is non inferior to alpha blockadeTimepoint: after study completion
Secondary Outcome Measures
NameTimeMethod
ess post operative hypotensionTimepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath